Developer docs
API playgroundTry for free, no card

Search company profiles

DayTwo

Full company profile

uuid0002w9l

Namestring
DayTwo
Legal namestring
DayTwo Ltd.
Websiteurl
daytwo.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

DayTwo is a precision nutrition company founded in 2015 that uses gut microbiome analysis combined with AI-driven glycemic response modeling to generate personalized dietary recommendations, primarily targeting health-conscious consumers and individuals managing blood sugar. Its core product is built on an AI platform that ingests microbiome composition, genetic markers, and metabolic response data to predict postprandial glycemic reactions to specific foods, replacing generic dietary guidelines with individualized nutrition plans augmented by virtual clinical support. The company is headquartered in Walnut Creek, California, operates as a private entity (DayTwo Ltd.), and employs 51-100 people, having raised approximately $90M across multiple funding rounds from 2016 through 2021 from investors including Johnson & Johnson, Mayo Clinic, aMoon Fund, Cathay Innovation, Samsung NEXT, Seventure Partners, and 10D.

The business model is consumer-facing with an implied subscription or test-and-program structure tied to microbiome profiling, though pricing is not publicly disclosed and no enterprise, payer, or employer channel details are available. DayTwo's strategic investor base (J&J for consumer health distribution, Mayo Clinic for clinical validation, Samsung NEXT for consumer data integration) signaled an attempted build-out across pharma, clinical, and consumer technology channels. Critically, several operational signals indicate material stress: the corporate website (daytwo.com) currently displays a parked GoDaddy landing page with no active product content, no funding round has been disclosed since the May 2021 Series B extension of approximately $37.4M, and no product launches, partnerships, or geographic expansions are visible in the available data. These signals collectively suggest that DayTwo's previously ambitious go-to-market may have contracted substantially since its 2021 capital raise, though no formal wind-down, restructuring, or acquisition announcement is disclosed in the source material.

Short descriptiontext

DayTwo is a precision nutrition company that uses AI-driven gut microbiome analysis and glycemic response modeling to deliver personalized dietary recommendations to health-conscious consumers and individuals managing blood sugar, supported by virtual clinical care.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBrentwood, United States
HQ citystring
Brentwood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
personalized nutrition, gut microbiome analysis, glycemic response prediction, precision nutrition, metabolic health
Industry2 codes
PRIMARYHSADAFAE
Medical Nutrition Therapy (Registered Dietitian)
SECONDARYHSADAFAA
General Nutrition Coaching
NAICS code1 code
  • Diet and Weight Reducing Centers812191
Product category
Personalized Nutrition
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

DayTwo provides AI-driven personalized nutrition services that analyze an individual's gut microbiome composition, genetic markers, blood biomarkers, and metabolic responses to predict glycemic responses and generate tailored dietary recommendations. The offering combines the proprietary AI platform with virtual clinical support to deliver precision nutrition guidance for metabolic disease management, replacing generic dietary guidelines with biology-based personalization.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Personalized Nutrition Program
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ZOE is the most directly comparable peer: a consumer subscription service combining gut microbiome testing, continuous glucose monitoring, and AI-driven personalized nutrition scores. DayTwo and ZOE pursue the same scientific thesis (microbiome + glycemic response) and the same D2C business model, making ZOE the primary head-to-head competitor.

TypeDirect peer
Description

Viome offers gut microbiome and RNA-based testing with personalized nutrition recommendations and supplements, overlapping directly with DayTwo's microbiome + AI + nutrition value proposition for health-conscious consumers.

TypeDirect peer
Description

InsideTracker provides blood biomarker-based personalized nutrition and wellness recommendations, sharing DayTwo's data-driven, biology-based approach to dietary personalization and serving the same health-conscious consumer segment.

4Noom
TypeDirect peer
Description

Noom is a large-scale consumer weight-management and behavior-change platform. It addresses overlapping glycemic and weight-loss use cases with a coaching/coaching-app model, and is repeatedly cited in the same market research as DayTwo.

TypeBroad incumbent
Description

Nestlé Health Science is a global nutrition incumbent with portfolio assets across medical nutrition, metabolic health, and personalized nutrition initiatives. It competes with DayTwo at the broad personalized-nutrition category level, especially for provider and consumer mindshare.

6Abbott
TypeBroad incumbent
Description

Abbott operates globally in diagnostics, medical nutrition (e.g., Glucerna), and metabolic health. It is a broad incumbent in the personalized/clinical nutrition space that could either compete with DayTwo or represent a strategic acquirer.

7Bayer Consumer Health
TypeBroad incumbent
Description

Bayer's consumer health division operates across supplements, nutrition, and digital health adjacencies and is listed alongside DayTwo in personalized nutrition market reports as a broad incumbent participant.

TypeBroad incumbent
Description

dsm-firmenich is a global nutrition, health, and ingredients company active in personalized nutrition partnerships and microbiome-related science, listed in the same market reports as a broad incumbent comparable to DayTwo.

TypeEmerging player
Description

Levels sells continuous glucose monitors paired with a software platform for metabolic-health insights. It overlaps with DayTwo's glycemic-response use case and shares a health-conscious, data-driven consumer target.

TypeEmerging player
Description

Habit (now part of Viome) was an early personalized nutrition service using biomarkers and biometrics to recommend individualized diets, sharing DayTwo's biology-first, consumer subscription model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DayTwo

Personalized Nutritiondaytwo.com

DayTwo is a precision nutrition company that uses AI-driven gut microbiome analysis and glycemic response modeling to deliver personalized dietary recommendations to health-conscious consumers and individuals managing blood sugar, supported by virtual clinical care.

What DayTwo does

DayTwo is a precision nutrition company founded in 2015 that uses gut microbiome analysis combined with AI-driven glycemic response modeling to generate personalized dietary recommendations, primarily targeting health-conscious consumers and individuals managing blood sugar. Its core product is built on an AI platform that ingests microbiome composition, genetic markers, and metabolic response data to predict postprandial glycemic reactions to specific foods, replacing generic dietary guidelines with individualized nutrition plans augmented by virtual clinical support. The company is headquartered in Walnut Creek, California, operates as a private entity (DayTwo Ltd.), and employs 51-100 people, having raised approximately $90M across multiple funding rounds from 2016 through 2021 from investors including Johnson & Johnson, Mayo Clinic, aMoon Fund, Cathay Innovation, Samsung NEXT, Seventure Partners, and 10D.

The business model is consumer-facing with an implied subscription or test-and-program structure tied to microbiome profiling, though pricing is not publicly disclosed and no enterprise, payer, or employer channel details are available. DayTwo's strategic investor base (J&J for consumer health distribution, Mayo Clinic for clinical validation, Samsung NEXT for consumer data integration) signaled an attempted build-out across pharma, clinical, and consumer technology channels. Critically, several operational signals indicate material stress: the corporate website (daytwo.com) currently displays a parked GoDaddy landing page with no active product content, no funding round has been disclosed since the May 2021 Series B extension of approximately $37.4M, and no product launches, partnerships, or geographic expansions are visible in the available data. These signals collectively suggest that DayTwo's previously ambitious go-to-market may have contracted substantially since its 2021 capital raise, though no formal wind-down, restructuring, or acquisition announcement is disclosed in the source material.

DayTwo firmographics

Firmographics
Name
DayTwo
Legal name
DayTwo Ltd.
Website
https://daytwo.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
DayTwo is a precision nutrition company that uses AI-driven gut microbiome analysis and glycemic response modeling to deliver personalized dietary recommendations to health-conscious consumers and individuals managing blood sugar, supported by virtual clinical care.
Ownership category
akta.pro rank

DayTwo industry classification

Industry
Product category
Personalized Nutrition
NAICS
Diet and Weight Reducing Centers (812191)
akta.pro industry
PRIMARYHSADAFAE
Medical Nutrition Therapy (Registered Dietitian)
SECONDARYHSADAFAA
General Nutrition Coaching

Keywords

  • Personalized nutrition
  • Gut microbiome analysis
  • Glycemic response prediction
  • Precision nutrition
  • Metabolic health

Where DayTwo is headquartered

Location

Headquarters

HQ city
Brentwood
HQ country
United States
HQ region
North America

Markets served

DayTwo business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

DayTwo product offering

Product offering

Core offering

DayTwo provides AI-driven personalized nutrition services that analyze an individual's gut microbiome composition, genetic markers, blood biomarkers, and metabolic responses to predict glycemic responses and generate tailored dietary recommendations. The offering combines the proprietary AI platform with virtual clinical support to deliver precision nutrition guidance for metabolic disease management, replacing generic dietary guidelines with biology-based personalization.

Differentiator

Problem solved

Functional benefit

Products and services

  • Personalized Nutrition Program

Companies that use DayTwo

Customer profile

Segments2 records

Ideal customer profiles2 records

DayTwo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

DayTwo partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

DayTwo competitors and assessment

Company assessment

Direct peers

  • ZOE: ZOE is the most directly comparable peer: a consumer subscription service combining gut microbiome testing, continuous glucose monitoring, and AI-driven personalized nutrition scores. DayTwo and ZOE pursue the same scientific thesis (microbiome + glycemic response) and the same D2C business model, making ZOE the primary head-to-head competitor.
  • Viome Life Sciences: Viome offers gut microbiome and RNA-based testing with personalized nutrition recommendations and supplements, overlapping directly with DayTwo's microbiome + AI + nutrition value proposition for health-conscious consumers.
  • InsideTracker: InsideTracker provides blood biomarker-based personalized nutrition and wellness recommendations, sharing DayTwo's data-driven, biology-based approach to dietary personalization and serving the same health-conscious consumer segment.
  • Noom: Noom is a large-scale consumer weight-management and behavior-change platform. It addresses overlapping glycemic and weight-loss use cases with a coaching/coaching-app model, and is repeatedly cited in the same market research as DayTwo.

Broad incumbents

  • Nestlé Health Science: Nestlé Health Science is a global nutrition incumbent with portfolio assets across medical nutrition, metabolic health, and personalized nutrition initiatives. It competes with DayTwo at the broad personalized-nutrition category level, especially for provider and consumer mindshare.
  • Abbott: Abbott operates globally in diagnostics, medical nutrition (e.g., Glucerna), and metabolic health. It is a broad incumbent in the personalized/clinical nutrition space that could either compete with DayTwo or represent a strategic acquirer.
  • Bayer Consumer Health: Bayer's consumer health division operates across supplements, nutrition, and digital health adjacencies and is listed alongside DayTwo in personalized nutrition market reports as a broad incumbent participant.
  • dsm-firmenich: dsm-firmenich is a global nutrition, health, and ingredients company active in personalized nutrition partnerships and microbiome-related science, listed in the same market reports as a broad incumbent comparable to DayTwo.

Emerging players

  • Levels: Levels sells continuous glucose monitors paired with a software platform for metabolic-health insights. It overlaps with DayTwo's glycemic-response use case and shares a health-conscious, data-driven consumer target.
  • Habit (formerly): Habit (now part of Viome) was an early personalized nutrition service using biomarkers and biometrics to recommend individualized diets, sharing DayTwo's biology-first, consumer subscription model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

DayTwo social profiles

Digital presence

DayTwo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DayTwo leadership team

Management profile

Number of profiles

Profiles11 records

DayTwo funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DayTwo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DayTwo

What does DayTwo do?

DayTwo provides AI-driven personalized nutrition services that analyze an individual's gut microbiome composition, genetic markers, blood biomarkers, and metabolic responses to predict glycemic responses and generate tailored dietary recommendations. The offering combines the proprietary AI platform with virtual clinical support to deliver precision nutrition guidance for metabolic disease management, replacing generic dietary guidelines with biology-based personalization.

Is DayTwo a public or private company?

DayTwo is a private company. It is classified as venture growth investor backed and is currently operating.

When was DayTwo founded?

DayTwo was founded in 2015. It employs 11 to 50 people.

Where is DayTwo based?

DayTwo is headquartered in Brentwood, United States, in the North America region.

Who are DayTwo's main competitors?

Direct peers on record are ZOE, Viome Life Sciences, InsideTracker and Noom. Broad incumbents are Nestlé Health Science, Abbott, Bayer Consumer Health and dsm-firmenich. Emerging players are Levels and Habit (formerly).

Does DayTwo have an API?

No public API is recorded for DayTwo.

What industry is DayTwo in?

DayTwo's product category is Personalized Nutrition. Its primary akta.pro industry code is HSADAFAE, Medical Nutrition Therapy (Registered Dietitian), with a secondary code of HSADAFAA, General Nutrition Coaching. Its NAICS code is 812191.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comAI-Driven Personalized Nutrition Market: The Science of Eating for Your Unique BiologyMarket Research Corridor published a market research report on the AI-Driven Personalized Nutrition Market, which is undergoing a paradigm shift from generic dietary guidelines to data-driven precision nutrition using genetic markers, gut microbiome composition, blood biomarkers, and metabolic responses. The market is segmented by measurement type (gut microbiome, genetic, blood/biomarker, metabolic monitoring), application (weight management, chronic disease, sports nutrition, immune health), and end user (DTC, wellness centers, hospitals, corporate wellness), with North America currently leading while Asia-Pacific emerges as the fastest-growing region. Key industry players include ZOE, Viome Life Sciences, DayTwo, InsideTracker, Noom, Nestlé Health Science, Bayer, Abbott, and DSM, as the sector navigates challenges including high costs, scientific skepticism, regulatory uncertainty, and data privacy concerns while pursuing opportunities in corporate wellness integration and insurance reimbursement.foodnavigator.comGut health: Innovations shaping a $51bn industryThe global digestive health products market is valued at over $51bn and projected to reach $68bn by 2030, driven by an 8.3% CAGR growth. Key innovations shaping the industry include microbiome-first functional foods, precision biotic interventions, AI-driven personalized gut diagnostics, and ingestible smart sensors, with companies like ZOE, Viome, DayTwo, DSM, ADM, Kerry, and PillTrek leading developments in this space.TracxnTop Companies in Personalized Nutrition Platforms (Oct, 2025)The article presents a ranking of top companies in the personalized nutrition platform sector, highlighting key financial metrics such as funding stages and total capital raised for each listed entity. It identifies Foodsmart, Day Two, Modify Health, and Field Doctor as leading startups, detailing their specific service models ranging from telenutrition to microbiome-based plans and chef-made meals. The data includes investor information and competitive rankings within the niche market.openPR.comVirtual Nutrition Coach App Market CAGR 16.17% Growth Outlook with Headspace, Nourishly, DayTwo, Eat This Much, GB HealthWatch, Asken Diet, Nashville Nutrition Partners, OnPoint NutritionThe Virtual Nutrition Coach App market is projected to grow at a compound annual growth rate (CAGR) of 16.17% from 2025 to 2032, driven by increasing demand for personalized health solutions and AI integration. Key market players identified include Headspace, Nourishly, DayTwo Ltd., Eat This Much, and other companies offering digital nutrition coaching services. The report, published by market research firm STATS N DATA, also notes regulatory hurdles and supply chain gaps as potential challenges to market expansion.The New York TimesHere Come the Artificial Intelligence NutritionistsTom Idema, a 50-year-old man with Type 2 diabetes, used the AI diet app DayTwo for nearly 500 days and achieved remission, dropping his blood sugar to normal range. He also lost 91 pounds, from 320 to 229 pounds. The app rates foods based on individual microbiome and blood sugar data.PR Newswire14th Annual Healthcare Revolution Conference Continues to Assist Self-Funded Employers in Reducing Costs, Improving Outcomes, and Reinventing Care DeliveryGlobal Healthcare Resources announced the 14th annual Healthcare Revolution conference, scheduled for April 26-27, 2022, as a virtual event for self-funded employers, brokers, and solution providers to address rising healthcare costs and benefits challenges. The conference sets three 'moonshots' for 2025: reducing employer healthcare costs by 25%, reimagining employee engagement and well-being, and providing 40% of healthcare services virtually. The event features sponsors including Lyra Health, Global Healthcare Accreditation, DayTwo, CLX Health, Korean Tourism Organization, Carrot Fertility, AKLOS Health, Big Health, and the Corporate Health and Wellness Association.KFF Health NewsMicrobiome Startups Promise to Improve Your Gut Health, but Is the Science Solid?Customers report months-long waits for Viome's gut health test results, with samples lost in transit, rejected for viability, or left unprocessed for up to five months, prompting CEO Naveen Jain to issue a public apology attributing the problems to a lab move and USPS logistics. The company, which sells $129 Gut Intelligence and $199 Health Intelligence tests, has since moved its operations from New Mexico to Washington State near its headquarters, where a new lab facility encountered equipment issues. The article investigates broader claims in the direct-to-consumer microbiome testing industry, including a Federal Bureau of Investigation raid on competitor uBiome, where co-founders were charged for fraudulent insurance billings, and contrasts Viome's struggles against rivals like Zoe and DayTwo, which claim robust scientific validation. These companies pitch personalized diet recommendations from stool and blood analysis, but experts warn the underlying science linking microbiome profiling to precise dietary prescriptions remains controversial, with limited peer-reviewed evidence supporting most claims.FinSMEsDayTwo Raises $37M in FundingDayTwo, a precision nutrition company based in Walnut Creek, California, raised $37 million in funding led by Cathay Innovation and aMoon. This latest round brings the company's total fundraising to $85 million as it operates under new CEO David Henderson. The capital will be used to support demand for its virtual care solution targeting metabolic diseases such as diabetes and obesity.GreenqueenGut Microbiome Nutrition Pioneer DayTwo Raises US$37M For Metabolic Diseases SolutionIsraeli precision nutrition startup DayTwo has raised US$37 million in a funding round led by existing and new investors to further develop its AI-driven gut microbiome sequencing technology. The capital will support the expansion of its app, which provides personalized dietary recommendations for diabetes and metabolic diseases, and fund research into new clinical solutions. The company is currently active in Israel and the U.S., partnering with health services like Clalit Health Services to demonstrate cost-saving clinical impacts.CTechMarius Nacht leading $37 million investment in DayTwoDayTwo, an Israeli diabetes and metabolic disease startup, raised $37 million led by Marius Nacht, with existing and new investors participating. The round brings total capital to $85 million, and the company plans to expand its workforce and collaborate with Maccabi Health Services.